| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-25-051576 |
2025-04-07 16:05:14 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-25-046163 |
2025-03-27 16:48:21 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-25-046056 |
2025-03-27 16:06:36 |
10-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-25-044549 |
2025-03-25 17:15:19 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-24-125929 |
2024-11-13 07:06:01 |
10-Q
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-24-125920 |
2024-11-13 07:00:09 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-24-114213 |
2024-10-11 08:00:08 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-24-059097 |
2024-05-14 08:00:12 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-24-059084 |
2024-05-14 07:31:40 |
10-Q
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-24-042789 |
2024-04-09 07:05:30 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-24-037627 |
2024-03-28 08:00:14 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-24-037618 |
2024-03-28 07:36:45 |
10-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-24-056937 |
2024-03-04 08:15:54 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-24-027629 |
2024-02-08 08:27:01 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-24-003885 |
2024-01-08 07:28:34 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-23-291705 |
2023-12-08 16:21:00 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-23-274124 |
2023-11-09 09:12:10 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-23-061553 |
2023-11-09 08:02:36 |
10-Q
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-23-228639 |
2023-09-05 17:23:10 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-23-209745 |
2023-08-11 07:17:52 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-23-041593 |
2023-08-11 07:11:33 |
10-Q
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-23-029447 |
2023-06-22 17:02:43 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-23-160789 |
2023-06-05 17:01:54 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-23-138948 |
2023-05-09 08:13:19 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-23-019157 |
2023-05-09 08:05:15 |
10-Q
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-23-129712 |
2023-05-01 12:25:54 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-23-128896 |
2023-05-01 08:42:02 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-23-114750 |
2023-04-25 11:27:09 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-23-010331 |
2023-03-28 16:45:46 |
10-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-23-081445 |
2023-03-28 08:06:28 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-23-068545 |
2023-03-13 08:51:38 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-23-060173 |
2023-03-03 17:08:07 |
8-K
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0000950170-22-026622 |
2022-12-15 16:52:13 |
10-Q
|
| 1781174 |
|
Acrivon Therapeutics, Inc. |
0001193125-22-287727 |
2022-11-17 16:50:01 |
8-K
|
